Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Clinical trial NCT03266640 · RECRUITING

Trial details

NCT number: NCT03266640
Sponsor: New York Medical College
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Infections Primary Immune Deficiency Disorder

Start date: 2018-11-01
Primary completion: 2026-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.